443 results on '"Fanaroff, Alexander C."'
Search Results
2. Investigating racial and gender disparities in virtual randomized clinical trial enrollment: Insights from the BE ACTIVE study
3. Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy
4. Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study
5. Association between racial residential segregation and Black-White disparities in cardiovascular disease mortality
6. Abstract 17514: Changing Default Prescription Length to Reduce Barriers to Statin Adherence
7. Development and Description of a National Cohort of Patients With Chronic Limb-Threatening Ischemia
8. A randomized controlled trial of gamification, financial incentives, or both to increase physical activity among patients with elevated risk for cardiovascular disease: rationale and design of the be active study
9. Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial
10. Racial Differences in Presentation and Outcomes After Peripheral Arterial Interventions: Insights From the NCDR-PVI Registry
11. Patient Management with Stable Ischemic Heart Disease
12. Independence of clinical events committees: A consensus statement from clinical research organizations
13. Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention
14. Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study.
15. Chronic Coronary Disease
16. Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy
17. Risk Prediction in Percutaneous Coronary Intervention: Solving the Last Mile Problem
18. Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
19. Association Between Diagnosis-to-Limb Revascularization Time and Clinical Outcomes in Outpatients With Chronic Limb-Threatening Ischemia: Insights From the CLIPPER Cohort.
20. Clinical outcomes and need for intensive care after non-ST-segment-elevation myocardial infarction
21. Radial Access for Peripheral Interventions
22. Standing up for equitable treatment of coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteries
23. High-Sensitivity Troponin in Patients With Cancer
24. Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials
25. Economic Considerations in Access to Transcatheter Aortic Valve Replacement
26. Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris
27. Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid Reperfusion
28. Antithrombotic Regimens in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: Trials Evaluating Patient-Centered Outcomes Needed
29. Association Between Cardiac Catheterization Laboratory Pre-Activation and Reperfusion Timing Metrics and Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Report From the ACTION Registry
30. Lack of Association Between Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement Outcomes in New York Hospitals
31. OR6-5 | Variation in Likelihood of Undergoing Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction among United States Hospitals
32. Patient and Staff Perceptions of Universal Severe Acute Respiratory Syndrome Coronavirus 2 Screening Prior to Cardiac Catheterization and Electrophysiology Laboratory Procedures
33. Racial, Ethnic, and Socioeconomic Inequities in Access to Left Atrial Appendage Occlusion
34. Abstract 13567: Variability in Reported Post-percutaneous Coronary Intervention Mortality Among Physicians Practicing at Multiple Sites in New York State
35. Association Between 90-Minute Door-to-Balloon Time, Selective Exclusion of Myocardial Infarction Cases, and Access Site Choice: Insights From the Cardiac Care Outcomes Assessment Program (COAP) in Washington State
36. Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis
37. Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events
38. Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial
39. Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies
40. COVID-19 Thrombotic Complications and Therapeutic Strategies
41. Antiplatelet Therapy in Percutaneous Coronary Intervention
42. Physiologic Assessment of Stent Deployment: SEARCHing for Answers With Post-Percutaneous Coronary Intervention Fractional Flow Reserve
43. Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials
44. Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention: Report From the NCDR CathPCI Registry
45. Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes
46. Fluoroscopic Guidance for Femoral Artery Access—Pushing Patients Out of the Plane Without a Parachute?
47. Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
48. Seeking patient-centered trial outcomes: The case for days alive out of hospital
49. A Path Forward for Regenerative Medicine: Navigating Regulatory Challenges: Summary of Findings From the Cardiac Safety Research Consortium/Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine
50. Focusing on the Future of Cardiovascular Outcomes Research: Highlights From the American Heart Association/American Stroke Association Quality of Care and Outcomes Research 2018 Scientific Sessions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.